SLR Investment (SLRC) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

SLR Investment

NasdaqGS•Financial Services•Asset Management

$12.57-0.06(<0.01%)Market closed

Market Cap

$668.29M

P/E

9.1x

P/S

3.2x

P/B

0.7x

SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $25million. The fund invests in companies with debt investments between $10 million and $50 million with revenues between $50 million and $1000 million and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.

How this company scores

AverageMetricSide Score: 45/100

Strongest: Cash & Earnings Quality (16/25); weakest: Growth (5/25).

Profitability15/25

Growth5/25

Balance Sheet & Red Flags9/25

Cash & Earnings Quality16/25

Strengths

Strong marginsCash-backed earningsImproving marginsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 9.1x5y range 8.5x – 32.5x

Currently near its 14-quarter median.

P/S · 3.2x5y range 3.2x – 4.0x

Currently near its 14-quarter median.

P/B · 0.7x5y range 0.7x – 0.9x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Watch

Operating margins declined 9.1% — watch for continued compression, which may signal competitive or cost pressure.

Revenue Decline

Red Flag

Revenue declined in 7 of the last 7 quarters — persistent contraction signals a fundamental problem.

Price & Volume

Market Cap $668.29M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $209.56M
Q. Revenue: $48.82M
TTM EBITDA: $82.17M
TTM Op. Income: $78.84M
Q. Op. Income: $17.76M
TTM Net Income: $73.77M
Q. Net Income: $8.27M
EPS: $0.15
Shares Out.: $54.55M

$209.56M in TTM revenue declined 5.8% YoY, reaching $48.82M last quarter. TTM EBITDA of $82.17M and TTM operating income of $78.84M show growth is flowing through to the bottom line. TTM net income of $73.77M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 7 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 38.1%
Op. Margin: 36.4%
Net Margin: 16.9%

Op. margin of 36.4% is down 3.7% YoY — costs are rising relative to revenue. Net margin at 16.9% Over the past year, operating margin is down 9% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 9.1x
P/S Ratio: 3.2x
P/B Ratio: 0.7x

At 9.1x P/E, the stock trades below typical market levels. P/S of 3.2x and P/B of 0.7x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 9% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.56B
Cash: $422.49M
Long-Term Debt: $1.15B
Book Value: $982.11M
D/E Ratio: 1.2
Debt/EBITDA: 62.0

With $2.56B in assets and $1.15B in long-term debt, D/E is 1.2and book value is $982.11M — moderate leverage. Over the past year, debt/equity is down 1% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $24.63M
TTM Free Cash Flow: $156.51M
FCF Margin: 74.7%
FCF / Net Income: 2.1

TTM FCF of $156.51M on $24.63M in operating cash flow. The FCF / Net Income ratio of 2.1x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 4% — an improving trend.